Are you Dr. Kummar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 16 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-314-7168
Summary
- Dr. Shivaani Kummar, MD is an oncologist in Portland, Oregon. She is currently licensed to practice medicine in Oregon, California, and Connecticut. She is affiliated with OHSU Hospital.
Education & Training
Lady Hardinge Medical CollegeClass of 1995
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology
Certifications & Licensure
CA State Medical License 2014 - 2026
OR State Medical License 2020 - 2025
MD State Medical License 1996 - 2018
CT State Medical License 2000 - 2004- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) Start of enrollment: 2015 Jan 01
Publications & Presentations
PubMed
- 549 citationsLarotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trialsDavid S. Hong, Steven G. DuBois, Shivaani Kummar, Anna F. Farago, Catherine M. Albert
The Lancet. Oncology. 2020-04-01 - 1600 citationsEfficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and ChildrenAlexander Drilon, Theodore W. Laetsch, Shivaani Kummar, Steven G. DuBois, Ulrik Lassen
The New England Journal of Medicine. 2018-02-21 - 45 citationsEfficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma.Steven G Waguespack, Alexander Drilon, Jessica J Lin, Marcia S Brose, Ray McDermott
European Journal of Endocrinology. 2022-04-29
Press Mentions
AACR Annual Meeting 2023: Phase III Immunotherapy Trials Offer Hope for Patients with Lung, Liver, and Biliary Tract CancersMay 4th, 2023- The Topic of CancerJune 16th, 2022
- OHSU Expands Capacity for Cancer Clinical TrialsAugust 25th, 2021
- Join now to see all
Professional Memberships
- Member
